The ASPC’s new Women’s Cardiovascular Health Working Group highlights sex-specific risk factors and prevention strategies, offering critical insights for improving outcomes in female patients - we spoke to co-Chair Dr Martha Gulati about the inception of the group and their goals for preventing cardiovascular disease in women.

New data to be presented at ACC 2026 suggest that shingles vaccination is associated with a reduced risk of major cardiovascular events, including myocardial infarction and stroke. In a large observational analysis, vaccinated individuals showed lower event rates within 12 months of follow-up. While the findings are subject to study limitations, they add to growing evidence linking infection prevention with cardiovascular risk reduction.

Hypertension affects over 1.4 billion adults worldwide and remains the leading modifiable risk factor for global cardiovascular (CV) morbidity and mortality. It is responsible for an estimated 10.8 million deaths annually and contributes significantly to the global burden of ischaemic heart disease, ...

Europe loses 1.7 million lives each year to cardiovascular disease, a burden that costs billions and affects millions more. The Safe Hearts Plan sets out an ambitious shift toward prevention, earlier detection and recognition of lifelong genetic risk. As expectations rise, debate is already growing over whether the strategy can translate bold goals into measurable improvements in care and outcomes across the EU.

Adult congenital heart disease is no longer a niche condition confined to childhood, but a lifelong and increasingly complex cardiovascular diagnosis. The new ACC/AHA guideline reframes care around continuity with specialised services, proactive mental health assessment, and encouragement of safe physical activity, signalling a shift from lesion-focused surveillance to holistic, life-course management that better reflects the realities facing today’s adult patients.

As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchCARDIO. From thought-provoking expert interviews and peer-reviewed research to dynamic conference coverage and an expanding portfolio of medical education, this year has been defined by meaningful conversations and impactful learning. We’ve had the privilege of engaging with leading clinicians, researchers and partner societies across the globe - bringing together diverse voices to support the cardiology community with timely, accessible and authoritative content. As we reflect on the past 12 months, we’re proud to highlight the moments, milestones and stories that shaped our year.

Cardiovascular medicine continues to advance at a remarkable pace, driven by innovation, interdisciplinary collaboration and an ever-deepening understanding of disease mechanisms. As patient populations age and chronic conditions become increasingly complex, the field stands at the intersection of precision therapy, ...

Heart failure (HF) is a complex and progressive clinical syndrome that significantly impacts morbidity, mortality and quality of life (QoL).1 On a global scale, HF has become an escalating public health concern, affecting more than 64 million individuals in 2017, and this ...

Heart failure (HF) is a global health burden, with a 2019 prevalence of 711.90 per 100,000 population, totalling 56.19 million cases and 5.05 million years lived with disability, despite only modest declines since 1990.1 Recent years have shown an uptick in prevalence, driven by ageing populations ...